Friday June 1 Press Briefing: ASCO Press Releases with links to abstracts

Treatment for Colorectal Cancer in Washington State Costs Twice as Much as in Neighboring Area of Canada, Despite No Difference in Survival

 “This study adds important context to the ongoing national conversation about rising treatment costs. As oncologists, we see the burden of high costs on patients and their families every day. In fact, as ASCO’s National Cancer Opinion Survey shows, many patients even forgo, delay or skimp on treatments due to costs, potentially compromising their effectiveness,” said ASCO Chief Medical Officer Richard Schilsky, MD, FACP, FASCO. 

CLICK TO SEE FULL TEXT of PRESS RELEASE including ABSTRACT

 

Geriatric Assessment Improves Communication Between Oncologists and Older Patients

 “As a society, we often think about the value of cancer treatments in terms of survival, but for older patients, we need to look beyond that. Geriatric assessments are clearly an effective tool to help us treat the whole patient. It’s a conversation starter that informs and empowers both patients and oncologists as we make decisions about their cancer care and overall health care together,” said ASCO Expert Joshua A. Jones, MD, MA. 

CLICK TO SEE FULL TEXT of PRESS RELEASE including ABSTRACT

 

Study Finds Gender Disparities in Head and Neck Cancer Treatment and Outcomes

 “We don’t know why women are getting less treatment and having worse outcomes, and we need to find out. Though these findings are specific to California, the disparities we see are startling and worth considering in treatment discussions in everyday practice,” said ASCO Expert Joshua A. Jones, MD, MA. 

CLICK TO SEE FULL TEXT of PRESS RELEASE including ABSTRACT

 

Abiraterone May Be More Effective in Black Men With Advanced Prostate Cancer Than in White Men

 “Racial and ethnic minorities continue to be underrepresented in clinical trials. This study should serve as a call for the entire cancer research community to make trials much more inclusive. When it comes to cancer treatments, people are not all alike, and it’s important to understand how different groups respond to different therapies,” said ASCO Expert Robert Dreicer, MD, MS, MACP, FASCO. 

CLICK TO SEE FULL TEXT of PRESS RELEASE including ABSTRACT

 

Black Men With Advanced Prostate Cancer Treated With Chemotherapy May Have Equal or Better Survival Than White Men

 “This study adds to the growing body of evidence showing that black men with advanced prostate cancer who participate in clinical trials have the same, if not better, chance of survival as white men. This research shows that by providing equal access to treatment, we can reduce racial disparities in outcomes for men with advanced prostate cancer,” said ASCO Expert Robert Dreicer, MD, MS, MACP, FASCO. 

CLICK TO SEE FULL TEXT of PRESS RELEASE including ABSTRACT